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The purpose of this evidence-based project was to provide patient education in 
order to increase human papillomavirus (HPV) vaccination rates in military women. 
Despite the availability of a vaccine, HPV continues to be the most common sexually 
transmitted infection (STI) in the United States. The goal of this program was to increase 
patient knowledge and HPV vaccination rates by providing education and a verbal 
recommendation for vaccination during regularly scheduled well-woman exams (WWE). 
The project resulted in a 65% increase in vaccination rates, raising the pre-program 
vaccination rate of 55% to a post-intervention vaccine percentage of 91%. The results 


















Sexually transmitted infections (STIs) are a persistent and costly health care 
burden in the United States. According to the Centers for Disease Control and Prevention 
(CDC), close to 20 million new STIs occur in the United States each year; with half of 
these occurring among our nation’s youth ages 15-24. Annual health care costs associated 
with STI treatment are about $16.4 billion (CDC, 2013). Human Papillomavirus (HPV) 
infection is the most common STI in the United States despite the availability of a 
vaccine. Vaccines such as Gardasil are the safest and most effective way to prevent 
cervical cancer and other HPV-related problems (CDC, 2013). While there is no cure for 
the virus, significant reductions in new HPV infections and reinfection rates are possible 
with vaccine administration.   
The Human Papillomavirus is extremely common. In fact, the American Cancer 
Society (ACS) compares genital HPV incidence to that of the common cold. They go on 
to state “nearly all sexually-active men and women get HPV at some point in their lives. 
This is true even for people who only have sex with one person in their lifetime” (ACS, 
2014). This is because most cases of HPV are asymptomatic, people are unaware they are 
infected, and over 90% of the time the body’s immune system will clear the virus on its 
own within two years (ACS, 2014). However, HPV remains the biggest risk factor for 
cervical cancer, and persistent infections with high-risk HPV subtypes (16 and 18) are 
associated with 99% of all cervical cancers (CDC, 2012).  
So, how big could HPV’s impact possibly be? In 2008 there were approximately 
14.1 million newly diagnosed cases of HPV, resulting in a prevalence of 79.1 million 
cases (CDC, 2013). Unfortunately, HPV has other associated complications beyond 
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cervical cancer. HPV accounts for 90% of anal cancers, 12% of oral and pharyngeal 
cancers, and 40% of vulvar, and vaginal and/or penile cancers (CDC, 2012). Another 
complication of HPV is anogenital warts caused by subtypes 6 and 11. An estimated 
360,000 Americans contract genital warts each year (ACS, 2015). These statistics are 
staggering and demonstrate the urgent need for intervention. 
The population of interest for this specific evidence-based program was U.S. 
Navy active duty servicewomen ages 17-26 stationed in San Diego, California. Thus, it is 
important to examine HPV prevalence in this specific group of women as well. 
According to Goyal, Mattocks, and Saddler (2012), there are significantly higher rates of 
STIs, HPV, and cervical dysplasia among young servicewomen than in civilian women.  
They believe this is because active duty servicewomen “tend to be young and unmarried 
and belong to racial and ethnic minority groups” associated with increased risk (Goyal et 
al., 2012, p. 1155). Goyal et al. (2012) went on to state: 
Although data are limited, the prevalence of HPV infection may also be higher 
among women in the military compared to those in the general population. In 
studies among active duty servicewomen seeking care at an Army Medical Center 
STI screening clinic, prevalence of any HPV type ranged between 36% and 
51%,48,49 which is far higher than in the general population of U.S. women (27%, 
95% confidence interval [CI] 23%-31%), but similar to that found in U.S. women 
20–24 years old (45%, (95% CI 36%-55%). (p. 1157) 
In another study, Shen-Gunther, Shank, and Ta (2011) examined HPV vaccination rates 
among different groups of patients at Naval Medical Center San Diego (NMCSD). The 
study looked at vaccine initiation and completion rates in a large group of 5,088 patients 
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and found that the least adherent group of patients was active duty service members.  
Although the vaccine is a covered benefit provided by TRICARE, only 16% of active 
duty servicewomen completed the vaccination series compared to 43% of dependent 
daughters and 21% of dependent wives. These results indicate that there is a problem 
with the system and a definite need for improvement in HPV education and vaccination.  
Intended Improvement 
 
HPV is a rapidly spreading problem and will continue to be so without adequate 
patient education. Thus, educating and informing patients about HPV and the HPV 
vaccine is crucial. By giving patients knowledge, we can empower them to take control 
of their healthcare and pass on the information to others. Thus, the clinical objective for 
this evidence-based project was to provide patient education about HPV and ways to 
prevent/minimize its negative effects. The expected outcome was improved HPV 
vaccination rates. 
Setting 
The project was initiated at a southern Californian Naval Medical Facility made-
up of a large multi-specialty inpatient hospital along with 10 branch clinics for military 
members and their families. The program took place at one of the branch clinics 
designated for active duty service members only. The program focused specifically on 
well women’s exams (WWEs) performed by a designated female nurse practitioner in the 
clinic. The clinical site has a large number of female patients in the targeted age range 
(17-26 years) that was easily accessible during their regularly scheduled WWEs. The 
program involved providing face-to-face patient education about HPV with educational 
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handouts and a specific provider recommendation for vaccination. The HPV vaccine was 
readily available, cost free and on-site after the visit. 
Study Question 
 
The project was designed to answer the following question: Does an educational 
HPV intervention result in an increased rate of HPV vaccination among U.S. Navy active 
duty females? With HPV incidence rates continually increasing, this is an area in which 
nurse practitioners can really make a significant impact and play a key role in 
intervention for individual patients, as well as the general public health. 
Conceptual Model 
 This particular evidence-based project was implemented using the Iowa Model for 
guidance. The Iowa Model of EBP was selected because it places an emphasis on 
visualizing the healthcare system as a whole and identifies several steps to assist and 
guide the practitioner in the EBP process. The model is broadly applicable and a variety 
of health care disciplines can utilize and reproduce the program in their settings. For this 
particular project, the identified problem and/or trigger was low HPV vaccination rates.  
Ethical Issues 
 Prior to implementation, project approval was obtained from the University of 
San Diego’s (USD) Institutional Review Board (IRB) with permission to disseminate de-
identified clinical findings. The project was also reviewed by the Regional Director of 








The intervention included face-to-face patient education, providing an educational 
handout, and giving a verbal recommendation for the HPV vaccine during regularly 
scheduled well-woman exams (WWEs). Patients checked-in for their regularly scheduled 
WWE and completed the women’s health intake form (which included a question about 
HPV vaccination status) prior to seeing the nurse practitioner. The nurse practitioner then 
completed the WWE and took time during each visit for patient education and health 
promotion. Patient education time was specifically dedicated to discussing HPV and the 
HPV vaccine. During this time, the practitioner provided an educational handout, 
answered any questions the patient had, emphasized the importance of the vaccine, and 
provided a verbal recommendation for vaccination. If interested in receiving the vaccine, 
the patient was then escorted directly to the immunization clinic (located on-site), where 
the vaccine was administered. The patient was given a magnet with the date for the next 
vaccination in the series. The practitioner then completed her documentation in the 
medical record and HPV vaccination was recorded. 
Evaluation Plan 
 
The program was monitored and evaluated through chart reviews via an electronic 
medical record (EMR) system. Chart reviews were conducted prior to beginning the 
program to collect pre-program data, during the program, and upon completion. Charts 
were screened for the HPV vaccination code and to see if the HPV vaccine had been 
documented. Patient follow-up was completed via email and phone call if they had not 
received the vaccine during the visit. Upon completion of the program, data were 




The goal of this program was to increase patient knowledge and HPV 
vaccinations rates by 20% from baseline, which was achieved and exceeded. The pre-
program vaccination rate was 55% and the post-intervention vaccination percentage 
increased to 91%, a 65% increase in vaccination rates. Throughout the 4-month program, 
103 eligible patients were identified as needing the HPV vaccination and out of those, 94 
patients were then vaccinated. Also, 100% of the patients seen during the program’s 
entirety received HPV education and a recommendation for vaccination if eligible. 
Discussion 
     The Human Papillomavirus is the most common sexually transmitted infection in 
the United States, yet public knowledge and vaccination rates remain low. Thus, this 
program set out to increase HPV awareness and increase vaccination rates among active 
duty servicewomen. The results of the program were impressive and in only 4 months, a 
65% increase in vaccination rates was seen. By providing patients with HPV education 
and recommending vaccination, the program created a new average vaccination rate of 
91% of eligible patients, up from the previous baseline of 55%.  
Another current organization encouraging HPV vaccination is the U.S. 
Department of Health and Human Services’ (USDHHS), and Healthy People 2020 
(HP2020) objectives seek to increase routine HPV vaccination coverage for adolescents. 
Immunization and Infectious Disease (IID) objectives 11.4 and 11.5 outline goals to 
increase HPV vaccination coverage for females (IID-11.4) and males (IID-11.5) ages 13-
15 to 80% (USDHHS, 2015). These target goals are important; however they only cover 
a specific age range and do not cover those females and males who were not vaccinated 
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as adolescents. There are no benchmark goals for older adolescents or young adults even 
though the Gardasil vaccine is approved for females and males ages 9-26. This evidence-
based program in military servicewomen exceeded the HP2020 benchmark vaccination 
goal of 80% for ages 13-15 years and demonstrated the importance of continuing to 
educate about HPV and encourage vaccination among older adolescents and young 
adults. 
 The program results suggest that education about HPV will improve vaccination 
rates. Thus, if health care providers educate patients, parents, and society about HPV, we 
may see an increase in vaccination. One of the main arguments against vaccination is a 
parental concern that it promotes sexual activity at a younger age. A recent study done by 
Jena, Goldman, & Seabury (2015), found that HPV vaccination was not associated with 
increased STI rates in a large cohort of females ages 12-18, suggesting that HPV 
vaccination is unlikely to cause unsafe sexual practices (Jena et al., 2015). Studies such 
as this one and evidence found from this project can be utilized by health care providers 
to have informed conversations with patients and parents about HPV to decrease 
concerns about vaccination.  
In conclusion, these results demonstrate the importance of patient and provider 
education about HPV and the need for vaccination recommendations from health care 
providers. Future evidence-based projects should replicate this program in other clinical 
sites to improve vaccination rates and increase awareness. 
Conclusions and Implications 
 
HPV is a rapidly spreading problem and will continue to be so without accurate 
patient education and vaccine recommendations from health care providers. By supplying 
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patients with knowledge, we can empower them to take control of their own health and 
inspire them to pass on their learned experience to others. Health care professionals play 
a key role in the patient education process and research has linked patient education and 
vaccine recommendations to increased acceptance of HPV vaccine. Cervical cancer is a 
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Table 1. 2014 HPV Vaccination Rates.	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Sarah Wedel, BSN, RN, DNP Student 
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BACKGROUND EVALUATION METHOD PRACTICE INNOVATION RESULTS 
•  The Human Papillomavirus (HPV) is the most common 
sexually transmitted disease in the U.S., despite the 
availability of a vaccine (American Cancer Society, 
2013) 
•  79 million Americans are currently infected with HPV, 
14 million individuals will become infected annually, 
leading to more than 10,000 cases of cervical cancer 
each year (CDC, 2013) 
•  Research demonstrates that young military 
servicewomen have significantly higher rates of STIs, 
HPV, and cervical dysplasia 
•  A U.S. Army medical center STI clinic found that HPV 
rates in service women ranged from 36-51%, which is 
higher than the U.S. general population (Goyal, 
Mattocks, & Saddler, 2012) 
•  Program took place at a southern California Naval 
Branch Health Clinic providing care to a large 
population of active duty servicewomen in the targeted 





•  The health care provider responsible for women’s 
health visits in an active duty military treatment 
facility provided patient education during regularly 
scheduled annual and/or initial well woman exams.  
•  Patients received an educational handout and a 
verbal recommendation for the HPV vaccine 
•  Immunizations were provided at the close of the 
visit, if desired  
•  Project effectiveness was evaluated based on 
changes in HPV immunizations rates before and 
after program implementation 
 
•  Project evaluated via electronic medical record 
(EMR) chart review 
•  Compared the number of patients coded by HCP for 
needing HPV vaccine and the number of individuals 
who actually received vaccination 
•  Pre-data gathered via EMR review and pre-
intervention vaccination percentage generated 
•  Post-data gathered via EMR review and post-
intervention percentage generated 
•  Compared pre-intervention percentage versus post-
intervention percentage to determine if practice 
change increased vaccination rates 
•  The goal of this program was to increase patient 
knowledge and HPV vaccinations rates by 20% 
from baseline which was achieved 
•  The average pre-data vaccination percentage was 
55% and the average post-intervention vaccination 
percentage was 91% 
•  Out of 103 eligible patients, 94 of them were 
vaccinated 
•  100% of patients received HPV education and a 
recommendation for vaccination if eligible 
 
•  Nearly every sexually active person will acquire HPV at some 
point in their lives (ACS, 2013) 
•  HPV is the biggest risk factor for cervical cancer (CDC, 2012) 
•  Vaccines such as Gardasil are currently considered one of the 
safest and most effective ways to prevent cervical cancer and 
other HPV related complications (CDC, 2013)  
•  Educational interventions to increase HPV awareness and 
vaccination help to boost vaccination rates (Kester, 2014) 
•  HPV vaccine uptake and acceptability increased when patients 
were given education and a recommendation for vaccination 
from their health care provider (Brewer & Fazekas, 2007)  
•  Patients were 5 times more likely to receive the HPV vaccine if a 
recommendation was given by their health care provider versus 










•  Based on the results of this program, patient education 
and health care provider recommendation for HPV 
vaccination increases HPV vaccination rates 
•  The intervention utilized in this program should be 
continued and implemented in similar clinical settings 
•  Vaccinating women and men against HPV could  
decrease HPV infection rates, re-infection rates, and 
cervical cancer incidence 
•  This program demonstrates the importance of patient 
education and provider awareness about HPV 
•  HPV vaccines could potentially decrease health care 




•  The purpose of this IRB approved evidence-based 
quality improvement project was to implement Human 
Papillomavirus (HPV) patient education during every 
well woman exam (WWE) to improve patient 
knowledge and HPV vaccination rates in military 
women aged 18-26 years 
•  This project was sponsored by the Jonas Center for 
Nursing and Veterans Healthcare via the Veterans 
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Figure 1. Number of patients vaccinated. This figure illustrates the total number of patients seen and 
percentage of those patients opting to be vaccinated 
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Project Purpose: The purpose of the project was to implement Human Papillomavirus 
(HPV) patient education during every well woman exam (WWE) to improve patient 
knowledge and HPV vaccination rates in military women aged 18-26 years. 
 
Background: The Human Papillomavirus (HPV) has been identified as the biggest risk 
factor for cervical cancer and, despite the availability of a vaccine; HPV continues to be 
the most common STI in the U. S. (American Cancer Society, 2013). Approximately 79 
million Americans are currently infected with HPV, and 14 million individuals will 
become infected annually, leading to more than 10,000 cases of cervical cancer each year 
(Centers for Disease Control and Prevention, 2014). Most cases of HPV are 
asymptomatic and people are unaware they are infected; thus, patient education and 
vaccination are key elements to battling the problem. Significant reductions in new HPV 
infections and reinfection rates are possible with patient education and vaccine 




Project Plan: The health care provider responsible for all women’s health visits in an 
active duty military treatment facility provided patient education during regularly 
scheduled annual and/or initial well woman exams. Patients received an educational 
handout and a verbal recommendation for the HPV vaccine. Immunizations were 
provided at the close of the visit, if desired. Project effectiveness was evaluated based on 
changes in HPV immunization rates before and after the project.   
 
Outcomes: The goal of this program was to increase patient knowledge and HPV 
vaccination rates by providing education and a verbal recommendation for vaccination 
during regularly scheduled well-woman exams (WWE). The project resulted in a 65% 
increase in vaccination rates, raising the pre-program vaccination rate of 55% to a post-
intervention vaccine percentage of 91%. 
 
Conclusions: The results of this evidence-based practice project demonstrate the 
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Background 
•  HPV is the most common sexually 
transmitted disease in the U.S. (American Cancer Society, 2014) 
•  79 million Americans currently infected 
o   14 million new cases/year (CDC, 2013) 
•  HPV is biggest risk factor for cervical cancer 
(CDC, 2012) 
•  Studies have found military servicewomen 
having higher rates of STIs, HPV, and 









               Background 
•  Increasing vaccination rates is nationally recognized by HP2020  
–  Immunization and Infectious Disease (IID) 
Objective IID-11: Increase routine vaccination coverage 
levels for adolescents 
•  IID-11.4: Increase the vaccination coverage level of 3 
doses of human papillomavirus (HPV) vaccine for 
females by age 13 to 15 years to 80% 
•  IID-11.5: Increase the vaccination coverage level of 3 
doses of human papillomavirus (HPV) vaccine for males 
by age 13 to 15 years to 80% 
–  NO BENCHMARK FOR OLDER ADOLESCENTS OR 
YOUNG ADULTS 
Is this clinically relevant? 
•  Studies have found military servicewomen having 
higher rates of STIs, HPV, and cervical dysplasia 
•  Baseline vaccination rates ranged from 48-67% 
(Average 55%) 
–  BELOW HP2020 BENCHMARK 
–  Area for improvement 
–  Potential to: 
•  Increase patient knowledge/awareness 
•  Improve health outcomes 
•  Empower patients to take control of their health care 
•  Reduce HPV infections and complication rates 










•  HPV patient education during all 
regularly scheduled well women’s exams 
(WWEs) and educational handouts 
were provided 
•  HCP provided verbal recommendation 
for HPV vaccine 
•  Escorted patients to immunization clinic 
immediately after visit if vaccination 
desired 
Cost Benefit Analysis 
•  Costs: 
–  Provider Salary (Covered by DON) 
–  Paper& ink for handouts (Covered by DON) 
–  Gardasil Vaccine (Covered by DON) 
•  Benefits: 
!  Increase health outcomes 
!  Reduce HPV infection and complication rates 
! DECREASE CERVICAL CANCER  
!  Decrease visits  
!  Cost savings 










Outcomes •  Goal was to increase 
baseline vaccination 
percentage by 20% 
•  Increased average 
vaccination 
percentage to 91% 
(65% increase) 
•  HIGHER THAN 
HP2020 GOAL 
•  103 patients eligible, 
94 vaccinated 











February$ March$ April$ May$ September$ October$ November$ December$
2014%HPV%Vaccine%Rates%
Intervention 
HPV Vaccination Rates 
Pre-Intervention: 
Feb 2014- 50% 
Mar 2014- 48% 
Apr 2014- 67% 
May 2014- 55% 
Average: 55% 
Post-Intervention: 
Sep 2014- 82% 
Oct 2014- 91% 
Nov 2014- 93% 










Conclusions & Implications 
for Clinical Practice 
•  HPV education and HCP recommendation 
INCREASE vaccination rates 
•  Educational intervention could potentially 
decrease HPV infection and complications 
•  Educational intervention with vaccination could 
potentially save the Navy millions of dollars 
•  Providers need to be educated! 
•  Intervention should be implemented in similar 
clinics 
 
Barriers & Lessons Learned 
•  Transient population (deployments, change of 
duty station) makes follow-up difficult  
•  Thus PATIENT EDUCATION IS KEY 
•  Provider Turnover/deployments 
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